UPPSALA, Sweden, July 14, 2022 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced it will release financial results for the second quarter of 2022 before the ...

Olink’s highly flexible made-to-order product, Olink® Flex, enables you to select and combine targets for up to 21 human proteins in one biomarker panel with results reported in absolute ...

Shares of Olink Holding AB are skyrocketing 66.1% higher as of 11 a.m. ET on Tuesday. The huge jump came after Thermo Fisher Scientific (TMO 0.59%) announced plans to acquire Olink for roughly $3. ...

For Olink shareholders, the current share price around $24.90 implies only a 4.4% total return based on the $26 deal price. This is not much different from T-Bill returns assuming 9.5 months until ...

Olink is a Health Care Tools and Service company focusing on leveraging the new high-growth field of proteomics. Olink just announced a dilutive offering and the share price fell over 16% on the news.

Olink also has limited sales and is losing money too -- both on a GAAP and free-cash-flow basis. Data by YCharts. However, parent-to-be Thermo Fisher is a highly profitable giant and has deep pockets.

Olink Reveal is more than a proteomics kit—it’s a gateway for anyone starting with proteomics. Whether profiling the reactome or interrogating inflammation biomarkers, validating clinical targets, or ...

Thermo Fisher Scientific Inc. will acquire Olink Holding AB in a deal that values the pharmaceutical products and services company at about $3.1 billion.